Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CymaBay Therapeutics, Inc. has filed 780 SEC EDGAR filings since 19 Feb 2002

SEC filing history

Showing 151-175 of 768 matching filings.

Per page
25
Current page
7
424B5 File 333-270796

424B5

Filing date
11 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
18 Aug 2023
Reporting date
18 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36500

144 filing

Filing date
18 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Aug 2023
Reporting date
15 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Aug 2023
Reporting date
15 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36500

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36500

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
11 Aug 2023
Reporting date
09 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-270795

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-263644

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-254697

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-229953

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-226741

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-223687

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-216905

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-210453

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-202941

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-198289

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-195211

S-8 POS

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-273887

S-8

Filing date
10 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36500

144 filing

Filing date
09 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
19 Jul 2023
Reporting date
18 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36500

144 filing

Filing date
18 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .